Literature DB >> 2305470

Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury.

S Rosen1, Z Greenfeld, M Brezis.   

Abstract

Cyclosporine CsA nephrotoxicity was examined in male Sprague-Dawley rats with or without prior uninephrectomy, injected daily with 12.5 mg/kg CsA, and fed a salt-depleted or normal diet for 3-10 weeks. Control rats received the CsA vehicle. CsA induced a fall in creatinine clearance in salt-depleted rats, from 1.3 +/- 0.1 to 0.8 +/- 0.1 ml/min (P less than 0.001), and in normally fed rats from 1.8 +/- 0.2 to 1.0 +/- 0.2 ml/min (P less than 0.02). Vehicle treatment had no effect. The most striking morphologic changes were those of thick ascending limb cell atrophy with concomitant fibroblastic proliferation and collagen formation; these alterations were present in the inner stripe of the outer medulla and the medullary ray. The medullary-ray findings included S2-S3 degenerative changes as well and apparently correspond to the striped fibrosis described in human CsA nephropathy. The alterations were specific to the CsA group, progressive, and most severe in the salt-depleted, CsA-injected rats (on a scale of 0-4: 1.7 +/- 0.2 for medullary rays, and 2.0 +/- 0.2 for inner stripe, P less than 0.001). Morphologic changes predicted renal failure (r = 0.3, P less than 0.01 for cortical alterations, and r = 0.5, P less than 0.001 for medullary alterations). Prior uninephrectomy did not enhance these changes. Thus, chronic CsA administration impaired kidney function and induced morphologic alterations found in regions characterized by, and in nephron segments particularly vulnerable to, limited O2 availability. Salt depletion appears to accelerate the development of chronic CsA renal injury in the rat.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2305470     DOI: 10.1097/00007890-199002000-00041

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

2.  Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.

Authors:  R G del Moral; M Andujar; C Ramírez; M Gómez-Morales; M Masseroli; M Aguilar; A Olmo; F Arrebola; M Guillén; M J García-Chicano; F F Nogales; F O'Valle
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

3.  Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy.

Authors:  K Muraoka; K Fujimoto; X Sun; K Yoshioka; K Shimizu; M Yagi; H Bose; I Miyazaki; K Yamamoto
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

4.  Prevention of chronic cyclosporine nephrotoxicity in Sprague Dawely rats: role of colchicine and omega-3-fatty acids.

Authors:  Alaa Sabry; Khaled El-Dahshan; Amr El-Hussieni
Journal:  Int Urol Nephrol       Date:  2007-02-27       Impact factor: 2.266

Review 5.  Established and newly proposed mechanisms of chronic cyclosporine nephropathy.

Authors:  Hye Eun Yoon; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2009-06-08       Impact factor: 2.884

6.  Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, prevents the development of cyclosporine A nephrotoxicity in a rat model.

Authors:  Shinya Morita; Kazunobu Shinoda; Tadashi Yoshida; Masayuki Shimoda; Yoshihiko Kanno; Ryuichi Mizuno; Hidaka Kono; Hiroshi Asanuma; Ken Nakagawa; Kazuo Umezawa; Mototsugu Oya
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-12       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.